Growth Metrics

Zimmer Biomet Holdings (ZBH) Net Cash Flow Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -32.51%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -87.87%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 42.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -11.49%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -87.88%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -48.90%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 129.29%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -65.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 33.47%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -51.65%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -51.65%
Dec 31, 2025 -56.88%
Sep 30, 2025 62.68%
Jun 30, 2025 -168.13%
Mar 31, 2025 96.57%
Dec 31, 2024 61.37%
Sep 30, 2024 47.61%
Jun 30, 2024 -52.89%
Mar 31, 2024 40.31%
Dec 31, 2023 34.92%
Sep 30, 2023 -28.00%
Jun 30, 2023 86.13%
Mar 31, 2023 -26.55%
Dec 31, 2022 -55.65%
Sep 30, 2022 14.00%
Jun 30, 2022 38.16%
Mar 31, 2022 37.78%
Dec 31, 2021 -182.19%
Sep 30, 2021 -63.92%
Jun 30, 2021 30.64%
Mar 31, 2021 -27.35%
Dec 31, 2020 -100.81%
Sep 30, 2020 123.00%
Jun 30, 2020 -42.04%
Mar 31, 2020 66.00%
Dec 31, 2019 -15.71%
Sep 30, 2019 30.66%
Jun 30, 2019 -197.76%
Mar 31, 2019 27.90%
Dec 31, 2018 71.00%
Sep 30, 2018 -0.69%
Jun 30, 2018 44.34%
Mar 31, 2018 -45.80%
Dec 31, 2017 -31.05%
Sep 30, 2017 28.95%
Jun 30, 2017 -109.63%
Mar 31, 2017 58.59%
Dec 31, 2016 0.69%
Sep 30, 2016 -64.90%
Jun 30, 2016 -28.31%
Mar 31, 2016 -28.47%
Dec 31, 2015 -27.74%
Sep 30, 2015 -30.31%
Jun 30, 2015 -624.27%
Mar 31, 2015 351.38%
Dec 31, 2014 -16.28%
Sep 30, 2014 29.17%
Jun 30, 2014 20.56%
Mar 31, 2014 -25.55%
Dec 31, 2013 38.77%
Sep 30, 2013 87.56%
Jun 30, 2013 -23.09%
Mar 31, 2013 -53.78%
Dec 31, 2012 -30.53%
Sep 30, 2012 -2.87%
Jun 30, 2012 -32.54%
Mar 31, 2012 -180.11%